Pfizer JV plans R&D center in China; Valeant to sell $1.75B in debt to pay for Medicis;

 @FiercePharma: Working Mother's Top 100 employers list includes 10 drugmakers. Discrimination lawsuits (for some) notwithstanding. More | Follow @FiercePharma

> Pfizer ($PFE) and its Chinese joint venture partner Zhejiang Hisun Pharmaceuticals is planning a dedicated research center to develop generic drugs for the Chinese market. Report

> Valeant Pharmaceuticals ($VRX) announced a $1.75 billion debt offering to help finance its planned acquisition of Medicis Pharmaceutical. Report

> Vertex Pharmaceuticals ($VRTX) tapped IBM enterprise marketing executive Yuchun Lee to join its board of directors. Report

> Xanodyne Pharmaceuticals won FDA approval for its Lysteda tablet to treat heavy menstrual bleeding, the first non-hormonal drug for the condition. Report

> Tranzyme Pharma said its stock offering delivered $11.5 million, including the underwriters' over-allotment. Report

Medical Device News

 @FierceMedDev: Japan's Olympus (makes med equipment/cameras) may be very close to getting a huge investment from Sony. WSJ reports. More | Follow @FierceMedDev

 @MarkHFierce: The U.S.'s othopedic soft tissue device market should grow to $2 billion by 2016, Millennium Research Group believes. More | Follow @MarkHFierce

 @DamianFierce: Torax Medical snagged $30M in VC funding to market its anti-acid reflux device. Story | Follow @DamianFierce

> U-Systems gains FDA nod for dense breast tissue cancer ultrasound. News

> Boston Sci, Medtronic reignite patent spat after court ruling. Article

Biotech News

 @FierceBiotech: Craigslist.com fuels biotech's hunt for flu therapies. Story | Follow @FierceBiotech

 @JohnCFierce: The Fierce 15: An appetite for risk is healthy in drug development. Report | Follow @JohnCFierce

 @RyanMFierce: 10 pharma giants form nonprofit to gang up on common R&D foes. More | Follow @RyanMFierce

> Baxter and Onconova ink $500M-plus licensing pact for PhIII cancer drug. News

> After FDA blessings for diet drugs, spotlight shines on biotechs' pioneering obesity meds. More

> Wellington Partners rounds up $91M for new European life sciences fund. Article

Drug Delivery News

> Fast migraine treatment battles sickness, too. Story

> BDSI's addiction oral patch approaches the market. Article

> Origami DNA may take twist out of doxorubicin delivery. News

> Ultrasound gets drugs right under the skin. More

Biomarkers News

> Genetic biomarkers and the frets of the 'worried well'. More

> Gene mutations point to personalized therapy in lung cancer. Story

> Breath biomarkers could breathe life into lung cancer tests. Article

> BRCA mutations may pinpoint response to Abbott's veliparib. News

And Finally ... A British study identified biomarkers that could improve depression treatment by identifying patients most likely to be resistant to standard therapy. Report

Suggested Articles

AbbVie and Allergan were already jumping through hoops for their merger before a new tax added hundreds of millions to the cost.

Avastin and Herceptin saw U.S. slowdown that's “not very pronounced” after bioisim launched, but Roche execs still warn of "a significant impact.…

Novo Nordisk, which recently completed a wastewater treatment plant for its massive U.S. API site, has made a gift of the $40 million facility.